This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 13 - 16, 2023
Marriott Marquis San DiegoLive In-Person Event: December 13 - 16, 2023

December 13 - 16, 2023
Marriott Marquis San Diego,
Live In-Person Event: December 13 - 16, 2023

2023 Call for Papers Now Open!


The latest science and research on antibody engineering, design and selection diving into critical topics including immuno-oncology, cellular engagers, miniproteins, the Fc region, cancer therapy, novel bi-specifics/multispecifics and much more!

Save up to $1000 on Super Early-Bird Savings!

Lock in the lowest rate that will ever be offered when you register by midnight Friday May 26, 2023. Save up to $1000 on your pass!

Celebrating 34 Years of Bringing The Community Together to Discuss Time-Critical Antibody Engineering Updates and Best Practices

Brand New Session Themes for 2023:

  • Pre-clinical Development of Antibody Drugs: From Discovery to IND
  • Artificial Intelligence and Machine Learning in Antibody Discovery
  • Antibody Discovery, Selection and Engineering
  • Antibody Therapy for Neurodegenerative Diseases
  • Inflammation and Tumor Microenvironment in Antibody Therapy
  • Engineering Antibody Immune Agonists
  • Bispecifics, Multi-specifics and Therapeutic Antibody Combinations

Brand New Session Themes for 2023:

  • Clinical Translation of Antibody Drugs and Lessons from ADCs
  • Protein-Based Degraders for Therapeutic Development
  • Non-Oncology Antibody Targets and Therapeutics
  • Advancing Antibody Therapeutics in Immuno-oncology
  • T-cell Engager Antibodies
  • Cell Therapy and CART
  • Single-domain Antibodies as Therapeutics: Nanobodies, VHH, VNAR, and Beyond

3 Unmissable Add-On Options for 2023:

Extend your learning even further with 3 vital add-on options designed to embed your knowledge prior to the main conference. 

Options include:

  • Pre-Conference Half-Day Workshop A (PM): Pre-clinical Development of Antibody Drugs: From Discovery to IND
  • Pre-Conference Half-Day Workshop B (PM): Artificial Intelligence and Machine Learning in Antibody Discovery
  • Pre-Conference Full-Day Training Course: Introduction to Antibody Engineering

Michael Kierny, PhD

Scientist I


With fascinating presentations from high caliber speakers, the Antibody Engineering conference is essential to understanding the advances in the field.

About the Antibody Society

The Antibody Society is an international, non-profit representing individuals and organizations involved in antibody-related research and development. The Society has a variety of initiatives and working groups focused on improving the antibody field. 

We are:

  • Creating opportunities for education and networking;
  • Monitoring and reporting advances in the commercial pipeline for antibody and CAR-T therapeutics;
  • Creating standards for characterizing antibody and T-cell receptor repertoires, and engaging this field;
  • Engaging government and international agencies on matters concerning the antibody community;

 Please join us!

Put Yourself Infront Of Key Antibody Decision-Makers!

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.

Contact Kristen Schott:

Vaishali Kapoor


Washington University in St. Louis School of Medicine

Great meeting! Good learning and networking experience.